Gossamer Bio, Inc. (4GB)
Munich
Real-time Data
06:00 AM
Day's Range
10.8852 wk Range
0.1415Overview - 4GB - Gossamer Bio, Inc.
Key Statistics
Valuation
Enterprise Value
2.00B
P/E (Trailing)
‪-0.20‬
PEG Ratio
‪-0.0082‬
Price / Sales (TTM)
‪0.84‬
Price / Book
‪1.30‬
EV / EBITDA
‪-14.06‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-328.99%‬
Return on Assets
‪-43.76%‬
Return on Equity
‪138.78%‬
Ownership
Shares Outstanding
234.69M
Float
190.24M
Held by Insiders
‪2.95%‬
Held by Institutions
‪87.82%‬
Price stats
Beta
‪1.90‬
50-Day Avg
‪2.61‬
200-Day Avg
‪1.94‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 4GB - Gossamer Bio, Inc.
Peers - 4GB - Gossamer Bio, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on Munich.
- 4GBMunichGossamer Bio, Inc.40.87MMarket Cap-1249.35%52-week change-0.21P/E (Trailing)‪0.00%‬Profit Margin
- 1AEAMunichargenx SE American Depositary Receipt53.48BMarket Cap+24.42%52-week change38.17P/E (Trailing)‪32.26%‬Profit Margin
- 0QFMunichModerna Inc.46.67BMarket Cap+82.72%52-week change25.19P/E (Trailing)‪-141.42%‬Profit Margin
- 5VAMunichVaxcyte Inc.7.66BMarket Cap+46.02%52-week change-9.15P/E (Trailing)‪0.00%‬Profit Margin
- 30JMunichIDEAYA Biosciences Inc.3.42BMarket Cap+39.15%52-week change-26.70P/E (Trailing)‪-74.75%‬Profit Margin
- 0MEMunichTwist Bioscience Corporation3.10BMarket Cap+80.10%52-week change-84.31P/E (Trailing)‪50.72%‬Profit Margin
- 4DNMunichDenali Therapeutics Inc.2.83BMarket Cap+38.28%52-week change-5.96P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - 4GB - Gossamer Bio, Inc.
About
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for serious cardiopulmonary and immune-mediated diseases. Its lead program is seralutinib, an investigational inhaled therapy being studied for pulmonary arterial hypertension and pulmonary hypertension associated with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
